Your search returned 14 results.

Sort
Results
1.
Reply to a. Avan et Al. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25870094
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Kiermaier A, Swain S
2.
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 24921704
Year: 2014
Citation:
  • Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • Lynce F, Swain SM
3.
Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 26982349
Year: 2016
Citation:
  • Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Gao J, Swain SM
4.
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25332247
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
5.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23868905
Year: 2013
Citation:
  • Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
6.
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24262440
Year: 2013
Citation:
  • Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
7.
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. MedStar authors:
  • Alsaadi, Dana
  • Charabaty, Aline
  • Jennings, Joseph
PMID:
  • 30518410
Year: 2018
Citation:
  • Journal for Immunotherapy of Cancer. 6(1):142, 2018 Dec 05.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Gastroenterology/Hepatology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abu-Sbeih H, Ali FS, Alsaadi D, Charabaty A, Gong Z, Jennings J, Luo W, Richards DM, Wang Y
8.
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
  • Weinstein, Arthur
PMID:
  • 24187095
Year: 2014
Citation:
  • Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Rheumatology
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
9.
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23530718
Year: 2013
Citation:
  • Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • O'Sullivan CC, Swain SM
10.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28988646
Year: 2017
Citation:
  • Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
11.
Advances in Stroke 2017. [Review] MedStar authors:
  • Zorowitz, Richard D
PMID:
  • 29669874
Year: 2018
Citation:
  • Stroke. 49(5):e174-e199, 2018 05.
Institution:
  • MedStar National Rehabilitation Network
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Amin-Hanjani S, Becker KJ, Bennett DA, Bernhardt J, Dichgans M, Ford GA, Goldstein LB, Goyal M, Greenberg SM, Howard G, Keller E, Kidwell CS, Olivot JM, Pantoni L, Pierot L, Planas AM, Reeves M, Saposnik G, Strbian D, Thrift A, Tymianski M, Woo D, Yenari MA, Zorowitz RD
12.
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 31900276
Year: 2020
Citation:
  • Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
13.
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23969513
Year: 2013
Citation:
  • Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
14.
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23685835
Year: 2013
Citation:
  • Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
Pages

Powered by Koha